← Back to Search

Behavioral Intervention

Sarcoidosis Patient Assessment and Resource Companion App for Sarcoidosis (SPARC Trial)

N/A
Waitlist Available
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up throughout the duration of the study, approximately 6 months
Awards & highlights

SPARC Trial Summary

This trial will evaluate whether a smartphone app can help manage stress and fatigue for people with sarcoidosis.

Eligible Conditions
  • Sarcoidosis
  • Fatigue

SPARC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~throughout the duration of the study, approximately 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and throughout the duration of the study, approximately 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants who achieve treatment satisfaction
Number of participants who complete the study
Number of participants who maintain adherence to twice daily breathing awareness meditation sessions
+1 more
Secondary outcome measures
Change in Sarcoidosis Associated Fatigue
Changes in Autonomous Motivation
Changes in Quality of Life
+2 more

SPARC Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SPARC GroupExperimental Treatment1 Intervention
Group II: Enhanced Standard Care Control GroupActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sarcoidosis Patient Assessment and Resource Companion App
2022
N/A
~50

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor
932 Previous Clinical Trials
7,394,210 Total Patients Enrolled
3 Trials studying Sarcoidosis
51 Patients Enrolled for Sarcoidosis
National Institute for Biomedical Imaging and Bioengineering (NIBIB)NIH
89 Previous Clinical Trials
19,734 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the primary objectives of this research endeavor?

"The key metric in this 6 month trial is treatment satisfaction. Secondary objectives include gauging changes in self-efficacy with the Fatigue Self-Efficacy Sale, Sarcoidosis Associated Fatigue using the 10 item scale of the Fatigue Assessment Scale, and Stress measured by Perceived Stress Scale's 0 to 40 range."

Answered by AI

Are any participants currently being accepted into this research study?

"Clinicaltrials.gov attests to this clinical trial's recruitment efforts, which began on February 23rd 2022 and were last updated at the end of July."

Answered by AI

What is the current enrollment of participants for this clinical trial?

"Affirmative, the posting on clinicaltrials.gov reveals that this investigation is recruiting participants. The initial advertisement of this research was posted on February 23rd 2022 and it has been revised most recently at July 31st 2022. This trial aims to recruit 50 individuals from 1 site."

Answered by AI

Who else is applying?

What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
SPARC Smartphone Application for the Management of Sarcoidosis-Associated Fatigue
W. Ennis James, MD 2022. "SPARC Smartphone Application for the Management of Sarcoidosis-Associated Fatigue". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05230693.
~16 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top